Vesta Health (603676.SH): Cooperative product injection of multiple vitamins (12) through generic drug consistency evaluation.

Zhixun Finance APP news, Weixinkang (603676.SH) announced that recently, the company's cooperating production partner Shanxi Pude Pharmaceutical Co., Ltd. (referred to as "Pude Pharmaceutical") received the Approval Notice for the supplementary application of injection of multiple vitamins (B12) issued by the National Medical Products Administration. The drug has passed the evaluation of generic drug quality and efficacy consistency. The injection of multiple vitamins (B12) is independently developed by the company, with Pude Pharmaceutical responsible for drug registration and production, making it a core product of the company.